MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The relationship between sleep and Parkinson’s disease progression: A Mendelian Randomization study

E. Matar, M. Mahjoub (Sydney, Australia)

Meeting: 2022 International Congress

Abstract Number: 1532

Keywords: Cognitive dysfunction, Parkinson’s, Sleep disorders. See also Restless legs syndrome: Etiology and Pathogenesis

Category: Parkinson's Disease: Pathophysiology

Objective: The objective of the study was to determine the causality between sleep disorders and progression of motor and cognitive endpoints of Parkinson’s disease.

Background: Sleep disturbances and disorders are common in Parkinson’s disease and significantly impact quality of life. Often, such sleep disturbances are considered sequelae of neurodegeneration affecting sleep-wake circuitry. However, there is emerging evidence that sleep disturbance may itself play a causal role in neurodegenerative processes via altered clearance of pathological proteins. Whether sleep disturbance affects the pathological progression of Parkinson’s disease is unknown. Recently, a several genetic variants have been discovered for sleep-related parameters through genome-wide association studies (GWAS) providing a unique opportunity to examine the evidence for causal relationships through the use of the Mendelian randomization.

Method: We performed two sample Mendelian randomization analysis using genetic variants identified from publicly available GWAS data for sleep variables including insomnia, sleep duration, chronotype, napping and daytime sleepiness as exposure variables. Outcome measures were derived from a large collective GWAS of PD progression (N=4093 cases) including the Unified Parkinson’s disease rating scale (UPDRS total and UPDRS- III), motor fluctuations, Age of onset of PD (PD-AOO), Mini-mental state examination (MMSE) and Montreal Cognitive Assessment (MOCA). The robustness of results was examined using conventional Mendelian randomization sensitivity analyses.

Results: Genetic liability to increased sleep duration was associated with a lower rate of progression of motor symptoms in PD using UPDRS-III score. Meanwhile insomnia was associated with increased rate of motor progression of PD. Predisposition to daytime sleep was associated with lower rates of progression of cognitive decline in PD measured using MMSE. No robust relationships were determined between markers of progression and chronotype or dayime napping. Statistical measures showed significant pleiotropy for the relationships identified.

Conclusion: Sleep-related variables may have a deterministic role in the clinical progression in Parkinson’s disease and may represent a modifiable target for altering the trajectory of neurodegeneration.

To cite this abstract in AMA style:

E. Matar, M. Mahjoub. The relationship between sleep and Parkinson’s disease progression: A Mendelian Randomization study [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/the-relationship-between-sleep-and-parkinsons-disease-progression-a-mendelian-randomization-study/. Accessed July 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-relationship-between-sleep-and-parkinsons-disease-progression-a-mendelian-randomization-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • #24970 (not found)
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley